Skip to Content

← See all NICORETTE brands

NICORETTE by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC

Medically reviewed on April 24, 2018

Dosage form: lozenge
Ingredients: NICOTINE 2mg
Labeler: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
NDC Code: 0135-0508

Drug Facts

Active ingredient (in each lozenge) (2 mg)

Nicotine polacrilex, 2 mg

Active ingredient (in each lozenge) (4 mg)

Nicotine polacrilex, 4 mg

Purpose

Stop smoking aid

Use
reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Warnings

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider.

Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Ask a doctor before use if you have
heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
stomach ulcer or diabetes
history of seizures

Ask a doctor or pharmacist before use if you are
using a non-nicotine stop smoking drug
taking a prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

Stop use and ask a doctor if
mouth problems occur
persistent indigestion or severe sore throat occurs
irregular heartbeat or palpitations occur
you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat
you have symptoms of an allergic reaction (such as difficulty breathing or rash)

Keep out of reach of children and pets.

Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions (2 mg Lozenge)
if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.
before using this product, read the enclosed User’s Guide for complete directions and other important information
begin using the lozenge on your quit day
if you smoke your first cigarette within 30 minutes of waking up, use 4 mg nicotine lozenge
if you smoke your first cigarette more than 30 minutes after waking up, use 2 mg nicotine lozenge according to the following 12 week schedule:

Weeks 1 to 6

Weeks 7 to 9

Weeks 10 to 12

1 lozenge every 1 to 2 hours

1 lozenge every 2 to 4 hours

1 lozenge every 4 to 8 hours

nicotine lozenge is a medicine and must be used a certain way to get the best results
place the lozenge in your mouth and allow the lozenge to slowly dissolve. Minimize swallowing. Do not chew or swallow lozenge.
you may feel a warm or tingling sensation
occasionally move the lozenge from one side of your mouth to the other until completely dissolved
do not eat or drink 15 minutes before using or while the lozenge is in your mouth
to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks
do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects
do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
it is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.

Directions (4 mg Lozenge)
if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.
before using this product, read the enclosed User’s Guide for complete directions and other important information
begin using the lozenge on your quit day
if you smoke your first cigarette more than 30 minutes after waking up, use 2 mg nicotine lozenge
if you smoke your first cigarette within 30 minutes of waking up, use 4 mg nicotine lozenge according to the following 12 week schedule:

Weeks 1 to 6

Weeks 7 to 9

Weeks 10 to 12

1 lozenge every 1 to 2 hours

1 lozenge every 2 to 4 hours

1 lozenge every 4 to 8 hours

nicotine lozenge is a medicine and must be used a certain way to get the best results
place the lozenge in your mouth and allow the lozenge to slowly dissolve. Minimize swallowing. Do not chew or swallow lozenge.
you may feel a warm or tingling sensation
occasionally move the lozenge from one side of your mouth to the other until completely dissolved
do not eat or drink 15 minutes before using or while the lozenge is in your mouth
to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks
do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects
do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
it is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.

Other information
each lozenge contains: sodium, 5 mg
store at 20 – 25oC (68 – 77oF)
keep vial tightly closed and protect from light

Inactive ingredients

acesulfame potassium, calcium polycarbophil, flavors, magnesium stearate, mannitol, potassium bicarbonate, sodium alginate, sodium carbonate, xanthan gum

Questions or comments?

call toll-free 1-888-569-1743

Principal Display Panel

NDC 0135-0508-02

Nicorette®

nicotine polacrilex lozenge, 2 mg

stop smoking aid

mini Lozenge

Mint

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE MORE THAN 30 MINUTES AFTER WAKING UP.

If you smoke your first cigarette WITHIN 30 MINUTES of waking up, use Nicorette®  4 mg Lozenge

81 LOZENGES, 2 mg Each

(3 Vials of 27)

Opening Directions:

Push in child resistant tab on the vial with thumb.

Flip up the top of vial. Turn upside down and shake to remove lozenge.

TO INCREASE YOUR SUCCESS IN QUITTING:

1.
You must be motivated to quit.
2.
Use Enough – Use at least 9 Nicorette® mini lozenges per day during the first six weeks.
3.
Use Long Enough – Use Nicorette® mini lozenges for the full 12 weeks.
4.
Use With a Support Program as directed in the enclosed User’s Guide.
not for sale to those under 18 years of age
proof of age required
not for sale in vending machines or from any source where proof of age cannot be verified

TAMPER EVIDENT FEATURE: Do not use if clear neckband printed "SEALED FOR SAFETY" is missing or broken. Retain outer carton for full product uses, directions and warnings.

For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.com or see inside for more details.

Trademarks are owned by or licensed to the GSK group of companies.

Distributed By:

GSK Consumer Healthcare

Warren, NJ 07059

Made in Switzerland

©2015 GSK group of companies or its licensor. All rights reserved.

104277XB

Principal Display Panel

NDC 0135-0509-02

Nicorette®

nicotine polacrilex lozenge, 4mg

stop smoking aid

mini Lozenge

Mint

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE WITHIN 30 MINUTES OF WAKING UP.

If you smoke your first cigarette MORE THAN 30 MINUTES after waking up, use Nicorette® 2 mg Lozenge

81 LOZENGES, 4 mg Each

(3 Vials of 27)

Opening Directions:

Push in child resistant tab on the vial with thumb.

Flip up the top of vial. Turn upside down and shake to remove lozenge.

TO INCREASE YOUR SUCCESS IN QUITTING:

1.
You must be motivated to quit.
2.
Use Enough – Use at least 9 Nicorette® mini lozenges per day during the first six weeks.
3.
Use Long Enough – Use Nicorette® mini lozenges for the full 12 weeks.
4.
Use With a Support Program as directed in the enclosed User’s Guide.
not for sale to those under 18 years of age
proof of age required
not for sale in vending machines or from any source where proof of age cannot be verified

TAMPER EVIDENT FEATURE: Do not use if clear neckband printed "SEALED FOR SAFETY" is missing or broken. Retain outer carton for full product uses, directions and warnings.

For more information and for a FREE individualized stop smoking program, please visit www.Nicorette.com or see inside for more details.

Trademarks are owned by or licensed to the GSK group of companies.

Distributed By:

GSK Consumer Healthcare

Warren, NJ 07059

Made in the Switzerland

©2015 GSK group of companies or its licensor. All rights reserved.

104255XB

NICORETTE 
nicotine polacrilex lozenge
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0135-0508
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (NICOTINE) NICOTINE2 mg
Inactive Ingredients
Ingredient NameStrength
POLACRILIN 
ACESULFAME POTASSIUM 
CALCIUM POLYCARBOPHIL 
MAGNESIUM STEARATE 
MANNITOL 
POTASSIUM BICARBONATE 
SODIUM ALGINATE 
SODIUM CARBONATE 
XANTHAN GUM 
Product Characteristics
ColorWHITE (white to off-white) Scoreno score
ShapeOVALSize10mm
FlavorMINTImprint CodeM
Contains    
Packaging
#Item CodePackage Description
1NDC:0135-0508-023 CONTAINER in 1 CARTON
127 LOZENGE in 1 CONTAINER
2NDC:0135-0508-035 CONTAINER in 1 CARTON
227 LOZENGE in 1 CONTAINER
3NDC:0135-0508-0420 LOZENGE in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02236003/01/2010
NICORETTE 
nicotine polacrilex lozenge
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0135-0509
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (NICOTINE) NICOTINE4 mg
Inactive Ingredients
Ingredient NameStrength
POLACRILIN 
ACESULFAME POTASSIUM 
CALCIUM POLYCARBOPHIL 
MAGNESIUM STEARATE 
MANNITOL 
POTASSIUM BICARBONATE 
SODIUM ALGINATE 
SODIUM CARBONATE 
XANTHAN GUM 
Product Characteristics
ColorWHITE (white to off-white) Scoreno score
ShapeOVALSize10mm
FlavorMINTImprint CodeF
Contains    
Packaging
#Item CodePackage Description
1NDC:0135-0509-023 CONTAINER in 1 CARTON
127 LOZENGE in 1 CONTAINER
2NDC:0135-0509-035 CONTAINER in 1 CARTON
227 LOZENGE in 1 CONTAINER
3NDC:0135-0509-0420 LOZENGE in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02236003/01/2010
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)

 
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide